Publication,

Rabbits Rejoice: End of Animal Testing in China...kind of

Current site :    CN   |   EN
Australia
Belgium
China
China Hong Kong SAR
Germany
Italy
Japan
Singapore
Spain
UAE
United Kingdom
United States
Global

How the new regulations will affect cosmetics in China

The China market has been problematic for many international beauty brands. 

On the one hand, by some measures China is already the world's largest cosmetics market and is still growing fast. According to the Chinese National Bureau of Statistics, the consumer goods sales in December 2021 increased by a healthy 4.6% on a year-on-year basis. However, cosmetics grew by 9.0%.

On the other hand, the broad requirement in China for animal testing on cosmetics would damage the brand amongst Western consumers who consider cruelty free as a core criteria when making purchasing decisions. 

This resulted in some cosmetic companies regretfully giving up their cruelty free position and some operating by way of exemptions to animal testing (i.e. cross border ecommerce sales or local manufacture with an exemption) in China. However, most decided it was not possible to enter the Chinese market until the regulations changed. With the promulgation of Administrative Provisions of Cosmetics Registration and Filing Documents (the "Provisions") — the regulations for animal testing in China have changed … kind of.

DOWNLOAD PUBLICATION
End of Animal Testing in China
How the new regulations will affect cosmetics in China

Download

959KB, 7 Pages

LATEST THINKING
Insight
New regulations in China designed to encourage innovation in clinical trials have made it easier to test human samples in a lab setting.

19 May 2022

Publication
Since 2017, KWM has issued the Series, Think Tank Report: Law and Practice under the Belt and Road Initiative. As the fifth instalment of the Series, this pamphlet comprises two parts: “Overview” and “Introduction by Countries”. Authored by KWM lawyers focusing on investment, financing, construction and projects, M&A, trade, compliance, and dispute resolution, this pamphlet will present you our experience and insights from different perspectives.

14 May 2022

Insight
Under the Chinese medical device regulatory regime, as filing/registration is compulsory prior to marketization, the legality of use of unregistered in vitro diagnostics reagents (“IVD”) in laboratory-developed testing (“LDT”) has been in a grey area for a long time.

10 May 2022